![](https://cannabisindustryjournal.com/wp-content/uploads/2023/01/IMG_6402-80x56.jpg)
![](https://cannabisindustryjournal.com/wp-content/uploads/2023/01/IMG_6402.jpg)
On January 10, 2023, seven dispensaries in Connecticut opened their doors to people over the age of 21, opening up the state’s new adult use cannabis market. The state legalized adult use cannabis back in June of 2021.
On January 10, 2023, seven dispensaries in Connecticut opened their doors to people over the age of 21, opening up the state’s new adult use cannabis market. The state legalized adult use cannabis back in June of 2021.
In this piece, we share some thoughts on progress made in 2022 and what’s in store for the year ahead. This includes a breakdown of legislation on the federal and state levels, a discussion of scheduling, Biden’s efforts and more.
In this six-part series of articles, the folks from AEssenseGrows introduce the 3-legged stool of successful cannabis cultivation: climate, cultivation & genetics. Parts 1, 2, 3, 4 and 5 covered environmental controls, water quality, critical housing requirements, integrated pest management and genetics, respectively. In Part 6, the final chapter, we cover consistency and repeatability through Standard Operating Procedures (SOPs).
As with any investment, VCs benefit from researching the company and market they are planning to invest in. In addition to making sure they have a thorough understanding of the business model and its value proposition, investors should also familiarize themselves with the company’s management team to make sure that they are knowledgeable and experienced in both running a company and the cannabis industry.
On December 29, New York’s first legal adult use dispensary opened its doors to customers with a ceremonious purchase made by Chris Alexander, executive director of the NYOCM. But with only one dispensary open heading into 2023, the state’s regulators are coming up short on their promises.
The 2022 Cannabis Labs Virtual Conference: December Program. Check out sessions from the December 19 event such as: Potency Inflation: The Problem, the Causes and the Solutions; The Laboratory Information Landscape in Cannabis Testing; and Cannabis Testing Regulations & Implications for Environmental Monitoring
Following up on Aaron Green’s conversation with Jushi Holdings Chief Creative Director Andreas ‘Dre’ Neumann last year, we check in to see what’s new with Jushi Holdings.
The first head-to-head pharma versus cannabinoid triple arm study is fully enrolled: How will this impact the future of medical cannabis research?
It was not the Green Wave of 2020, but two more states did join the growing number of states that have legalized cannabis for adult-use. Specifically, Maryland passed its ballot measure by a large margin, and Missouri passed its measure by a slimmer margin.
The U.S. cannabis market will face an array of challenges in 2023 but companies can protect their products, people and bottom lines with thoughtful risk management strategies that can keep operations running.